Rights and permissions
About this article
Cite this article
Irbesartan reduces progression of renal disease in type 2 diabetes. Inpharma Wkly. 1290, 15–16 (2001). https://doi.org/10.2165/00128413-200112900-00032
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200112900-00032